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sychological Distress
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oland von Känel, MD
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bundant literature has been accumulated on the relation-
hip between psychological stress and cardiovascular disease
CVD) (1). The first scientific quote about the brain
ffecting the heart and emotion-triggered cardiovascular
hanges leading to heart disease dates back 4 centuries. In
628, the English physician William Harvey noted that
every affection of the mind that is attended either with pain
r pleasure, hope or fear, is the cause of an agitation whose
nfluence extends to the heart” (2). Nowadays affections of
he mind refer to the numerous environmental challenges
etting the stage for the development of biological alter-
tions, which several decades down the line will manifest as
vert cardiovascular events. Chronic psychosocial stressors
s diverse as job strain, marital conflict, family caregiving,
nd low socioeconomic status have been previously shown
o be predictive of CVD independent of classic cardiovas-
See page 2156
ular risk factors (3–6). Conceptually, life circumstances
ttain the status of psychological stressors if a person
erceives an amount of threat and challenge that he or she
udges to overwhelm current coping resources (7). Depend-
ng on the quantity and quality of stress appraisal, accom-
anying neurobiological and neuroendocrine activation pat-
erns shape the stress response to elicit a wide range of
nitially adaptive physiological, behavioral, and emotional
hanges in an attempt to maintain homeostasis (8). The
tress response becomes maladaptive in individuals under
hronic stress exposure and fosters low-grade systemic
nflammation and coagulation activity, poor lifestyle habits,
nd elevated levels of negative affect (9–12). This explains
hy negative emotions like depression, anxiety, and hope-
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
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ern, Switzerland. Dr. von Känel has received funding from Pfizer Inc., Switzerland.essness considered together as psychological distress have
merged as risk factors of CVD in their own right (13).
Behavioral cardiology has come a long way in identifying
he biobehavioral pathways leading from chronic psycho-
ogical stressors and perceived psychological distress, respec-
ively, to hard CVD end points (13). However, because
ehavioral and pathophysiological stress responses to some
xtent intertwine, it remains a challenge to disentangle their
elative contribution to CVD. For instance, a highly stressed
ndividual is more likely to smoke than a person who copes
elatively better with stress. Smoking kindles inflammation,
hich in turn accelerates atherosclerosis progression. Addi-
ionally, chronic stress elicits inflammation by altering
utonomic nervous system function (14). How much of the
ariance in the stress-related CVD risk is attributable to
moking-triggered inflammation, and how much is ac-
ounted for by a direct autonomic effect on inflammation?
hese questions are of clinical and public health importance
like because they may prompt tailored behavioral interven-
ions directed at smoking cessation in the first scenario (13)
nd toward restoring vagal function by relaxation techniques
n the second instance (14).
In this issue of the Journal, Hamer et al. (15) address
ome of these topics by prospectively studying 6,576 healthy
iddle-age community-dwelling men and women from the
cottish Health Survey. The investigators found that psy-
hological distress rated by the 12-item version of the
eneral Health Questionnaire predicted an increased risk of
ncident fatal and nonfatal CVD events combined after a
ean follow-up of 7 years. The likelihood of experiencing a
ardiovascular event during follow-up was 54% increased in
ndividuals with psychological distress relative to those
ithout, whereby a gradual relationship between psycholog-
cal distress severity and CVD risk also was observed. Most
mportant, the investigators found behavioral factors to
ccount for 65% of the relationship between psychological
istress and CVD risk and pathophysiological factors to
xplain an additional 19% after controlling for behavior. In
ther words, their model left but 16% of the variance in
actors linking psychological distress with CVD unex-
lained. Smoking, decreased physical activity, and hyper-
ension accounted for the majority of the variance, whereas
lcohol consumption and increased C-reactive protein
xplained comparably lower proportions. Interestingly
nough, psychological distress also predicted all-cause mor-
ality, with behavioral and pathophysiological factors ex-
laining a substantial proportion of the variance. This
upports the long-stated notion that psychological distress
ight indeed impact the risk of developing various diseases
y adversely affecting health behavior and physiology (16).
The large sample permitted collection of a reasonably
igh number of CVD events and definition of a level of
sychological distress that seemed clinically meaningful
ecause less than one-sixth of subjects were defined to be
sychologically distressed at enrollment. The results of this
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Stress and CVD December 16/23, 2008:2163–5ntriguing investigation need to be discussed within the
imitations of the study design. Psychological distress as well
s behavioral and pathophysiological factors were all as-
essed at study entry. Therefore, a bidirectional relationship
annot be discounted. Only repeated measurements of data
oints during follow-up might have allowed identifying
ore causally associated relationships in their trajectories.
he comparably small number of 63 fatal CVD events
revented an analysis of nonfatal and fatal cardiovascular
vents as separate outcomes. Different types of CVD (i.e.,
oronary heart disease, heart failure, cerebrovascular disease)
lso had to be combined in 1 outcome variable to gain
nough statistical power. An even larger population would
e necessary to differentiate among the relative contribu-
ions of psychological distress to the risk of fatal CVD
vents, nonfatal CVD events, and the individual entities of
VD. This may seem too cost intensive; however, we must
cknowledge that behavioral factors and pathophysiology
lay partially different pathogenetic roles in chronic heart
ailure and stroke as an example. Although its score corre-
ates reasonably well with scores of more specific instru-
ents to rate depression and anxiety, the 12-item General
ealth Questionnaire comprises items related to depres-
ion, anxiety, and poor sleep that in their own right have
een shown to predict CVD risk in apparently healthy
opulations (17–19). Poor sleep quality and associated
bstructive sleep apnea are prevalent in the community and
re variably associated with hypertension, inflammation,
nd psychological distress, particularly depressed mood
19–22). Additional adjustment for sleep quality and disor-
ers might have accounted for some of the residual nonex-
lained variance of the distress–CVD relationship. Separate
uestionnaires to rate depression, anxiety, and sleep quality
ight have revealed whether these dimensions are equally
mportant predictors of CVD risk in relation to the medi-
ting behavioral and pathophysiological risk factors. There
s a vast literature on biological alterations in depression in
ddition to low-grade inflammation, including autonomic
mbalance, endothelial dysfunction, and platelet hyperactiv-
ty (23). An interesting hypothesis to test is whether in
epression, relative to general psychological distress, patho-
hysiology contributes a comparably greater proportion to
VD risk. Biomarker status is ideally assessed at several
oints in time because a single blood draw to determine
-reactive protein as in the study by Hamer et al. (15)
eflects only an erratic estimate of inflammatory status.
Cardiovascular diseases are projected to be the leading
ause of death in the year 2020 worldwide (24), with a
onsiderable amount of this risk being attributable to
sychological stress (25). Psychosocial intervention studies
iming at the modification of psychological distress to
educe mortality in patients with CVD are cumbersome to
erform and show mixed results (26,27). Whether preven-
ive reduction of psychological distress in a healthy commu-
ity will ultimately reduce CVD mortality is unknown. In
pite of these uncertainties, the results from the study byamer et al. (15) encourage clinicians to consider behav-
oral interventions to target intermediate pathways linking
sychological distress with CVD manifestation (13,14).
ith regard to the investigators’ findings, clinicians might
ragmatically be recommended to exercise a multimodal
herapeutic approach to the psychologically distressed indi-
idual at risk for CVD. Specifically, behavioral interventions
argeting smoking cessation and increasing physical exercise, as
ell as blood pressure-lowering and inflammation-lowering
elaxation techniques, are best delivered in combination with
sychotherapeutic and psychopharmacologic means aimed at
irectly alleviating psychological distress. To conclude, ran-
omized clinical trials testing the hypothesis that such multi-
odal treatment programs will not only show benefit with
egard to the quality of life but also decrease stress-related
VD morbidity and mortality are sorely needed.
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